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Abstract: 
To prepare temperature and pH dual-responsive drug delivery systems, the 
thermosensitive polymer poly(N-isopropylacrylamide) (PNIPAAm) was first 
synthesized by free-radical polymerization. It was then co-dissolved with the 
pH-sensitive polymer Eudragit
®
 L 100-55 (EL100-55) and processed into fibers using 
electrospinning. Ketoprofen (KET), a model drug, was also incorporated into the 
composite fibers, and fibers based on a single polymer additionally prepared. The 
fibers had smooth cylindrical morphologies, and no obvious phase separation could be 
seen. Using X-ray diffraction, KET was determined to be present in the amorphous 
state in the fiber matrix. FTIR spectroscopy also indicated the successful 
incorporation of amorphous KET in the fibers. In vitro drug release studies in media 
at different pH (4.5 or 7.4) or temperature (25 and 37 ºC) showed that the release of 
KET from the blend PNIPAAm/EL100-55 fibers was dependent both on 
environmental temperature and pH, reflecting the dual-responsive properties of the 
fibers. The MTT assay was used to explore the biocompatibility of the 
PNIPAAm/EL100-55 composite fibers towards L929 fibroblasts. Viability was always 
found to be > 80 %, even at polymer concentrations of 100 mg/mL. Therefore, the 
fibers prepared here could lead to the development of multi-responsive fibers for drug 
  
delivery and tissue engineering.  
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1. Introduction: 
 
In recent years, electrospun fiber-based drug delivery systems (DDSs) have drawn 
great attention from the research community. Electrospinning, being a relatively 
simple and cost-effective technique, has become a commonly used method to produce 
non-woven nanoscale fibers [1, 2]. The resultant mats have several intrinsic benefits 
including high porosity, tunability, a high surface area-to-volume ratio, and a similar 
structure to the extracellular matrix in tissues. Electrospun fibers can also have high (> 
50%) drug loadings and good biocompatibility, important properties for potent DDSs 
[3-8]. By careful selection of the drug loading modality and the material used to 
develop the fibers, the drug release rates can be tuned [9]. Different active ingredients 
can be loaded into the fibers, and the drug location in the polymer matrix controlled 
[10]. In addition, a large number of polymers (ca. 100) have been successfully 
fabricated into electrospun fibers. This includes thermosensitive and pH sensitive 
polymers.  
 
Poly(N-isopropylacrylamide) (PNIPAAm) is one of the most commonly explored 
temperature-sensitive polymers, and undergoes a rapid phase transition at a lower 
critical solution temperature (LCST) of 32 ºC in aqueous solution. When the 
temperature is increased through the LCST, PNIPAAm changes abruptly from being 
hydrophilic to hydrophobic [11-13]. PNIPAAm has been successfully electrospun into 
fibers, and also studied in the context of drug delivery [14-15]. For instance, in our 
previous work DDSs based on PNIPAAm and ethyl cellulose (EC) were prepared by 
both blend electrospinning and coaxial electrospinning; both systems had 
temperature-dependent drug release properties. [16-17].  
 
  
The Eudragit family of polymers are well known pharmaceutical excipients developed 
by the Röhm Company in Germany. They are based on polymethacrylates and have 
been widely used in the preparation of extended and delayed release formulations. 
Eudragit L100-55 (EL 100-55) (methacrylic acid - ethyl acrylate copolymer type A, 
1:1 molar ratio), is a pH-dependent copolymer which is highly soluble in water above 
pH 5.5, but insoluble below this pH. To date, EL 100-55 has been extensively used for 
the formulation of dosage forms including as enteric tablet coatings, microspheres, 
nanoparticles and fibers. These systems have been investigated for various 
applications, particularly colon-targeted drug delivery [18-20]. For instance, 
EL100-55 fibers loaded with diclofenac sodium (DS) were successfully prepared 
using an electrospinning process and demonstrated to possess pH-dependent drug 
release profiles [21].  
 
DDSs based on responsive polymers could have a number of promising drug delivery 
properties, and hence such “smart” polymers have explored extensively [22], 
including in the preparation of DDSs responsive to more than one stimulus. To date, a 
number of studies into dual-responsive DDSs using temperature and pH responsive 
polymers have been reported [23-27]. For example, Li et al. developed a series of 
biodegradable multi-sensitive poly(ether-urethane)s [28]. An aqueous solution of 
these multi-segment copolymers underwent a sol-to-gel phase transition with 
increasing temperature and pH. In addition, the controlled release of insulin could be 
achieved [28]. In other work, Chen et al. synthesized a series of dual-responsive block 
copolymers containing poly(ε-caprolactone) and poly(triethylene glycol) units, which 
formed micellar structures in aqueous solutions. The 6-aminocaproic 
acid-functionalized copolymer possessed pH-sensitive phase transitions at mildly 
acidic pHs and body temperature. Doxorubicin-loaded micelles prepared from this 
polymer showed increased drug release at acidic pH, and more potent anti-cancer 
activity than free doxorubicin in mice [29]. To date, most reports of temperature and 
pH dual-responsive DDS are based on hydrogels and self-assembled micelles. Further, 
they tend to rely on the generation of new copolymers, which often means that the 
  
preparation of these materials is complicated and time consuming.  
 
In this work, we adopt a more straightforward approach by simply combining a 
pH-sensitive and a thermoresponsive polymer. PNIPAAm was employed as the latter, 
and EL100-55 the pH-sensitive material. Through blend electrospinning, 
PNIPAAm/EL100-55 composite fibers could be produced. Ketoprofen (KET), a 
non-steroidal anti-inflammatory drug, was selected as a model active ingredient and 
incorporated into the composite fibers to form a dual-responsive drug delivery system. 
Morphological and physicochemical characterizations, in vitro drug release, and 
biocompatibility assays were undertaken.   
  
2. Experimental: 
2.1 Materials 
N-isopropylacrylamide (NIPAAm) was procured from Japan TCI (Japan). 
Phosphate-buffered saline (PBS), sodium azide, penicillin, trypsin and thiazolyl blue 
(MTT) were purchased from Sigma-Aldrich Ltd. (USA). Azobisisobutyronitrile 
(AIBN), anhydrous ethanol, acetone, formaldehyde and n-hexane were provided by 
the Sinopharm Chemical Reagent Co., Ltd (China). Eudragit L 100-55 (average 
molecular weight approximately 135,000 Da) was supplied by Rohm GmbH 
(Germany). Ketoprofen (KET) was procured from Beijing J&K Scientific Co., Ltd. 
(China). L929 cells were obtained from the Institute of Biochemistry and Cell 
Biology (Chinese Academy of Sciences, China). Dimethyl sulfoxide (DMSO) and 
DMEM culture medium were sourced from Jinuo Biological Medicine Technology 
Ltd. (China). All other chemicals used were analytical grade, and water was doubly 
distilled before use. 
 
2.2 PNIPAAm synthesis 
Free-radical polymerization was used to synthesize PNIPAAm, following protocols 
used in previous work [30]. 5.0 g NIPAAm and 25.0 mg AIBN were dissolved in 10 
mL anhydrous ethanol, and the reaction system heated at 70 ºC under a positive 
  
pressure of N2 for 7 hours. The products were then precipitated in n-hexane. The 
crude product was subsequently re-precipitated from 50 mL of acetone into 200 mL of 
n-hexane three times, and the purified material dried for 3 days in a vacuum oven 
(DZF-6050, Shanghai Laboratory Instrument Work Co. Ltd., China). Successful 
polymerization was confirmed by 
1
H nuclear magnetic resonance (AV-400 instrument, 
Bruker, Germany) and IR spectroscopy (Nicolet-Nexus 670 FTIR spectrometer, 
Nicolet Instrument Corporation, USA). Molecular weights (Mw, Mn) and molecular 
weight distributions were tested by gel permeation chromatography (GPC) 
measurements on a Waters LS measurement system (Waters, USA) with 
tetrahydrofuran (THF) as the solvent. The flow rate was 1.0 mL/min, and the column 
temperature was 35 ºC. The molecular weight distribution was calibrated with 
standard polystyrene samples. 
 
2.3 Preparation of electrospinning solutions 
PNIPAAm and EL100-55 were dissolved into ethanol under magnetic stirring for 8 h 
at room temperature to yield clear and homogenous solutions. The component ratio of 
PNIPAAm to EL100-55 was 1:1 (w:w), and the total concentration of polymer 20 % 
(w/v). Solutions of PNIPAAm and EL100-55 alone (20 % w/v in ethanol) were also 
prepared as controls. The model drug KET was added into selected solutions at a drug 
to polymer ratio of 1:5 (w:w). Full details of the solutions prepared are listed in Table 
1. 
 
  
  
Table 1. Details of the electrospinning solutions prepared in this work.  
 
Sample 
 
Solution contents 
PNIPAAm to EL100-55 
ratio (w/w) 
KET  concentration 
(% w/v) 
S1 PNIPAAm/EL100-55 1:1 --- 
S2 PNIPAAm --- --- 
S3 EL100-55 --- --- 
S4 PNIPAAm/EL100-55 1:1 4.0 
S5 PNIPAAm --- 4.0 
S6 EL100-55 --- 4.0 
  
2.4 Electrospinning  
The required solution was loaded into a 5.0 mL plastic syringe, which was fitted with 
a stainless steel needle (internal diameter 0.5 mm) and placed on a syringe pump 
(KDS100, Cole-Parmer, USA). A flow rate of 1.0 mL/h was used for electrospinning, 
with a voltage of 16 kV applied (ZGF-2000 power supply, Shanghai Sute Electrical 
Co. Ltd., China). The distance between the grounded collector and needle tip was 20 
cm. Spinning was conducted at ca. 40 % relative humidity, and at room temperature 
(25 ºC). As soon as the solution in the syringe was finished, the syringe was refilled 
immediately. Each experiment was performed for 8 h, after which the fiber mats were 
produced were removed from the collector and stored in a vacuum oven at room 
temperature for 24 h to remove any residual solvent. 
 
2.5 Fiber characterization  
The fibers were imaged using a scanning electron microscope (SEM; JSM-5600 LV 
microscope, JEOL, Japan) at a voltage of 10 kV. Prior to scanning, the samples were 
gold sputter-coated under argon for 60 s to make them electrically conductive. The 
ImageJ software (National Institutes of Health, USA) was used to calculate the 
average fiber diameter of each sample by analyzing ca. 100 fibers in each of the SEM 
images. Cross-sections of the nanofibers were prepared by immersing them into liquid 
  
nitrogen and then manually breaking the mats. 
 
X-ray diffraction (XRD) was undertaken on a D/Max-BR diffractometer (Rigaku, 
Japan), which was supplied with Cu Kα radiation (40 kV / 30 mA). Patterns were 
collected over the 2θ range 5–60º. Fourier transform infrared spectroscopy (FTIR) 
data were obtained using a Nicolet-Nexus 670 FTIR spectrometer (Nicolet Instrument 
Corporation, USA). Spectra were acquired over the range 500–4000 cm−1 at a 
resolution of 2 cm
−1
.  
 
2.6 In vitro drug release 
Drug release experiments were conducted at two different temperatures (25 or 37 ºC) 
and in media at two different pH values (pH 7.4 PBS and pH 4.5 acetic acid buffer) at 
110 rpm in a thermostatic shaking incubator (Jintan Instrument Co. Ltd., China). 50 
mg of each fiber mat was separately immersed in 30 mL of a release medium. At 
predetermined time points, 1 mL of the test medium was withdrawn and an equal 
amount of fresh pre-heated medium added. The amount of KET released was 
determined using a UV-vis spectrometer (UV-1800, SHJH Company, China) at a 
wavelength of 265 nm, following construction of a calibration curve. All release 
studies were performed in triplicate, and the results are given as mean ± S.D. 
  
2.7 Cytotoxicity measurements 
The in vitro cytotoxicity of samples was investigated with the aid of MTT assays. 
L929 fibroblasts were employed and cultured in DMEM medium supplemented with 
10 % v/v FBS and 1 % v/v penicillin–streptomycin solution. For cell viability 
measurements, 200 μL of cell suspension was seeded into 96-well plates at a density 
of 10
4
 cells/well. After incubation (37 ºC, 5 % CO2) overnight, the medium was 
removed and fresh medium containing different concentrations (100, 50, 25 mg/L) of 
fibers S4, S5 or S6 was added. Blank DMEM was used as a negative control. After 
incubation for another 24 hours, the culture medium in each well was replaced by 180 
μL of fresh DMEM and 20 μL of an MTT solution (5 mg/mL thiazolyl blue in PBS). 
  
The plates were shaken for 30 min at room temperature, before 200 μL DMSO was 
added to each well and the plates incubated for 6 h. The resultant purple solution in 
each well was used to determine the number of cells, which was assessed via the OD 
values at 570 nm. The latter were quantified on a microplate reader (Multiskan, 
ThermoFisher, USA). The relative cell viability was measured by comparing the 
treatment wells to the control containing the untreated cells in DMEM (deemed to 
have 100% viability). 
 
3. Results and discussion: 
3.1 PNIPAAm synthesis 
Successful polymerization of NIPAAm was verified by 
1
H NMR data (Fig. 1). The 
polymer (Fig. 1(a) displays no methylene protons, while these are clearly visible for 
the monomer (NIPAAm, Fig. 1(b)) at ca. 5.5 and 6.3 ppm. Instead, PNIPAAm has 
signals at around 1.5 and 2.1 ppm. These are typical of saturated systems and agree 
with a previous study [30], indicating the successful formation of PNIPAAm. FTIR 
spectra (Fig. 2) confirm the successful synthesis of PNIPAAm. There is a sharp band 
at 1621 cm
-1
 (C=C stretching vibration) in the spectrum of NIPAAm, which 
disappears after polymerization. GPC characterization determined that the molecular 
weights (Mw and Mn) and molecular weight distribution (PDI) of the PNIPAAm 
product were 50,052, 63,899, and 1.67, respectively. 
 
Fig. 1  
 
 
Fig. 2 
3.2 Fiber morphology 
SEM images and the diameter distributions for the electrospun products (S1-S6) are 
shown in Fig. 3. The images confirm that regular cylindrical fibers have been 
successfully produced under all the conditions used in this study. The blend fibers S1 
have larger average diameter (1116 ± 290 nm) than pure PNIPAAm (S2, 891 ± 188 
  
nm) and EL100-55 (S3, 976 ± 208 nm) fibers. With the addition of KET, the average 
diameters of the fibers increased: the average diameters of S4, S5 and S6 are 1396 ± 
284 nm, 1097 ± 225 nm and 1015 ± 212 nm, respectively. A cross-sectional image of 
the S4 fiber mat was also obtained (see Fig. S1, Supporting Information): this shows 
the fiber cross-sections are smooth and homogeneous. There is no phase separation 
evident, suggesting an even dispersion of drug in the polymer carrier.  
 
Fig. 3  
 
3.3 X-ray diffraction  
XRD patterns of pure KET and all the fibers are given in Fig.4. It is apparent that for 
KET there are a number of characteristic reflections at 6.5°, 13.2°, 14.0°, 18.0°, 20.2°, 
21.5°, 23.0°, 23.8°, 26.5° and 29.8° 2θ, indicating the crystalline nature of the pure 
drug. This is consistent with the literature [31]. In contrast, none of the fibers show 
any Bragg reflections. S2 and S5 (PNIPAAm based) display two weak and broad 
diffuse peaks at around 8º and 23º 2θ in their patterns, while the other formulations 
have no distinct features. The fibers are thus all amorphous materials. The 
characteristic reflections of KET do not appear in the KET-loaded fibers (S4-S6), 
demonstrating that these systems comprise amorphous solid dispersions. Similar 
results have been reported in many previous studies in the literature [32-34]. The 
formation of amorphous products  can be attributed to the rapid solvent evaporation 
which occurs in electrospinning. As a result, there is insufficient drying time for the 
molecular organization required to form a crystal lattice [35, 36]. The random 
arrangement of molecules in the solution phase is thus propagated into the solid state, 
resulting in a molecular dispersion of KET in the fibers.  
 
Fig. 4  
 
3.4 FTIR spectroscopy 
  
FITR spectra of pure KET and the fibers (S1-S6) are presented in Fig. 5. Neat 
PNIPAAm fibers (S2) display a broad band between around 3700 and 3000 cm−
1
, 
which corresponds to H-bonded N-H stretches (3284 cm−
1
) and amide I and II 
combination and overtone bands [37]. Two characteristic peaks at 2967 cm−
1
 and 1644 
cm−
1
 result from C-H and C=O stretching vibrations, respectively. The distinct band at 
1538 cm−
1
 arises from C-N stretching and N-H bending vibrations. The pure Eudragit 
L100-55 fibers (S3) exhibit a broad band characteristic of hydroxyl groups (O-H 
stretching) from 3700 to 2400 cm−
1
. They also show methyl and methylene C-H 
stretching vibrations at 2998 cm−
1
 and 2930 cm−
1
. A strong band from carbonyl groups 
is present at 1731 cm−
1
, and two bands from ester linkages at 1278 and 1184 cm-
1
 can 
also be seen [21]. The drug free composite fibers (S1) have two distinct peaks at 1638 
and 1725 cm−
1
 arising from C=O stretching in PNIPAAm and the C-O stretch of 
EL100-55, respectively. This confirms the presence of both polymers in the blend 
fibers. 
KET has two key peaks at 1693 and 1656 cm
-1
, representing the stretching vibrations 
of its carboxylic acid group and ketone group respectively. The peak at 1654 cm
-1
 can 
also be observed in the drug-loaded EL100-55 fibers (S6), confirming the 
incorporation of KET into S6. For S4 and S5, the characteristic peaks at 1636 (S4) 
and 1644 cm
-1 
(S5) have been enhanced compared with the drug free analogues S1 
and S2, again ratifying the presence of KET in the fibers. However, the peak at 1693 
cm
-1
 cannot be seen in the drug-loaded fibers. This can be explained by the phase 
transformation which KET undergoes during the process of electrospinning. In its 
crystalline form, KET molecules are bound together in dimers through intermolecular 
hydrogen bonds, resulting in the appearance of the distinct peak at ca. 1693 cm
-1 
[38, 
39]. The absence of this band in the KET-loaded samples suggests a lack of dimers 
and crystalline structure, which is accordance with the results from XRD. KET is also 
known to show a triplet at ca. 704 cm
-1
 when crystalline and doublet at this position 
when it is in the amorphous form. The triplet can clearly be seen for the raw KET 
material. The low intensity of these peaks in the fibers’ spectra makes these peaks a 
  
little hard to see, but on close inspection it appears that only a doublet is present. This 
is again consistent with KET being molecularly dispersed throughout the polymer 
carriers. 
 
Fig. 5  
 
3.5 Drug release 
The results of in vitro release studies are presented in Fig. 6. Experiments were 
performed in two different media (PBS and acetic acid buffer) at two temperatures, 25 
and 37 ºC. 
 
Fig. 6  
 
For the EL100-55/KET fibers (S6), the release behavior looks similar at both 25 and 
37 ºC, but there are distinct differences between the profiles seen in the two different 
media. In PBS (pH 7.4), the fibers fully dissolved after about 10 h, with more than 80 % 
of the KET loading released. By the end of the experiment (100 h), the cumulative 
release of KET from the S6 EL100-55/KET fibers at 25 and 37 ºC reached similar 
values of 91.5 % and 92.3 %, respectively. However, S6 showed lower release rates in 
AA compared to PBS. These observations arise because EL 100-55 is only soluble 
above pH 5.5. In AA media (pH 4.5), EL100-55 is insoluble, resulting in 75.3 % and 
72.9 % of KET being released at the end of the 25 and 37 ºC experiments, respectively. 
While it is possible that a small amount of the KET in the spinning solution might 
have been lost during electrospinning, this is expected to be very minimal (no more 
than 5 % at most). Thus, where the fibers show distinctly less than 100 % release it is 
believed that this is a result of some of the KET being encapsulated deep inside the 
fibers (and thus not diffusing to the surface during the timescale of the experiment).  
 
The solubility of EL100-55 is controlled by the extent of ionization of the COOH 
groups in the polymer [40]. Drug release from matrix drug delivery systems such as 
  
those produced here is typically controlled by diffusion, dissolution, or a combination 
of the two [41]. In AA, diffusion will be the rate limiting step to KET release from S6, 
because EL100-55 is insoluble in this medium: thus, the only way the embedded drug 
can escape into solution is to diffuse through the carrier. However, EL100-55 is 
readily soluble in PBS, and thus polymer dissolution is expected to be relatively rapid. 
This allows accelerated release, and also a greater percentage of the incorporated drug 
to be freed into solution. 
 
For the PNIPAAm/KET (S5) fibers, the release behavior differed with temperature. At 
25 ºC, around 70 % of the drug loading was released in PBS in the first 10 h and 83.1% 
at 100 h. At 37 ºC, after an initial burst release of 35 % in the first 10 h, the fibers 
showed gradual release over about 90 hours and reach only 57.5 % at the end of the 
experiment. The results in AA are very similar. In this case, when the temperature is 
below the LCST of PNIPAAm (32 ºC), the C=O and N-H groups in the PNIPAAm 
chains will interact with water molecules to form intermolecular hydrogen bonds [42]. 
As a result, PNIPAAm has good wettability, leading to rapid release. When the 
temperature is above the LCST, the C=O and N-H groups form intramolecular 
hydrogen bonds, resulting in a globular hydrophobic polymer matrix and slower 
release [30]. 
 
The composite S4 fibers containing both EL100-55 and PNIPAAm with KET 
combine the benefits of both temperature and pH responsiveness (Fig. 6), with the 
PNIPAAm leading to a slowing of release at 37 ºC and the EL100-55 slowing it at pH 
4.5. Release is thus fastest in 25 ºC PBS and slowest in 37 ºC AA. The 
temperature-responsiveness of the system is particularly marked at pH 4.5, with the 
difference between release at 25 and 37 ºC less noticeable at pH 7.4. Clearly, drug 
release from S4 is sensitive to both pH and temperature. The release mechanism is 
thus expected to combine both that of S5 and that of S6, with diffusion of the drug 
dominating when the polymers are insoluble (in AA at 37 °C), dissolution when both 
PNIPAAm and EL100-55 are soluble (in PBS at 25 ºC). When only one polymer is 
  
soluble (in AA at 25 ºC, or PBS at 37 ºC), we suggest that both dissolution and 
diffusion will be important. The soluble polymer will dissolve freely, taking drug 
associated with it into solution. This dissolution will leave pores in the fibers, 
facilitating the diffusion of drug associated with insoluble polymer into solution. 
 
This system has potential clinical benefit in several fields, such as hemodialysis. 
Hemodialysis patients are vulnerable to catheter-related bloodstream infection 
(CRBSI), a life-threatening condition. This is because they are implanted with 
catheters which remain in place for a long period of time and accessed frequently, 
leading to frequent opportunities for infection. This is particularly problematic 
because many hemodialysis patients have compromised immune systems. The 
estimated number of CRBSI cases is approximately 250,000 annually in the United 
States, with an incidence of ca. 1.65 infections per 1000 central line days (the total 
number of days patients have a central line in place). In Asia, the infection rate has 
been reported to be of 6.8 infections per 1000 central line days [43, 44]. An 
antimicrobial-loaded drug delivery system with the same dual-responsive nature as 
those prepared in this work (i.e. where drug release is accelerated at temperatures 
below the usual physiological temperature, and at neutral pHs) could be employed in 
the catheter to inhibit the growth of microorganisms. Catheters usually operate outside 
the body, at temperatures below 37 ºC, and thus when the catheter is in use drug 
release will be more rapid than when it is between uses. A low-level drug release rate 
will continue during the gaps between treatments, however. Further, when blood 
(pH>7.0) is running through the catheter, the drug release rate will be further 
enhanced due to the elevated pH. Thus, it is believed that such dual-responsive 
materials have great potential in designing novel targeted drug delivery systems.  
 
3.6 Cytotoxicity 
The cytotoxicity of solutions of the drug-loaded fibers (S4-S6) to L929 was 
investigated using the MTT assay. As shown in Fig. 7, no obvious toxicity was 
observed for S4, S5 and S6, even at high concentrations. At final concentrations of 
  
100 mg/L, the cell viability was 82.7 ± 3.9 % (S4), 81.6 ± 4.3 % (S5) and 85.7 ± 4.4 % 
(S6), indicating that the fibers have very high biocompatibility. This reflects the 
non-toxic nature of both polymers as reported in previous work [16, 30].  The data 
for S5 (PNIPAAm/KET) show slightly lower viability that S4 and S6, because 
PNIPAAm shows slight toxicity to cells, as has been noted previously [16]. In contrast, 
EL100-55 is FDA-approved for the formulation of oral dosage forms and has 
extremely high biocompatibility. Overall, the blend PNIPAAm/EL100-55 fibers did 
not show cytotoxicity to L929 cells, indicating their great potential as dual-responsive 
drug carriers.  
 
 
Fig 7.  
4. Conclusions: 
In this work, the thermo-responsive polymer poly(N-isopropylacrylamide) 
(PNIPAAm) was first synthesized by free-radical polymerization. Fibers containing 
both PNIPAAm and Eudragit
®
 L 100-55 (EL100-55) were then prepared by blend 
electrospinning, with both blank polymer fibers and those loaded with the model drug 
ketoprofen (KET) generated. Control fibers containing a single polymer were also 
produced. SEM images showed that all the fibers have cylindrical morphologies, with 
average diameters lying between 896 and 1396 nm. There was a tendency for 
diameter to increase with the addition of KET to the formulations. X-ray diffraction 
and infrared spectroscopy revealed that KET was present in the amorphous state in 
the fibers. In vitro drug release studies at different temperatures and pH showed that 
the KET release profiles are dependent on both temperature and pH for the 
PNIPAAm/EL100-55 composite fibers. Further, the fibers are highly biocompatible 
with the L929 cell line. PNIPAAm/EL100-55 fibers thus have potential as effective 
and biocompatible dual-responsive systems for drug delivery. 
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Fig. 1 
1
H NMR spectra of (a) PNIPAAm and (b) NIPAAm. The solvent peak (H2O) 
appears at 4.7 ppm. 
 
 
 
  
 
 
Fig. 2 FTIR spectra of PNIPAAm and NIPAAm 
 
  
 
Fig. 3 SEM images and diameter distributions of the fibers. The scale bar in the SEM 
images represents 50 µm. 
 
  
 
Fig. 4 XRD patterns of the fibers and pure KET. 
 
 
 
 
  
 
Fig. 5 FTIR spectra of the fibers and pure KET. 
 
  
 
Fig. 6 The in vitro release profiles of KET from the drug-loaded fibers in (a) PBS 
(pH7.4) and (b) acetic acid buffer (pH4.5). Data are reported as mean ± S.D. from 
three independent experiments. 
 
 
 
  
 
Figure 7. MTT assay results of all the formulations. Data are reported as mean ± S.D. 
from three independent experiments. 18wells for each condition in each experiment 
were used to test in each independent experiment.  
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Table 1. Details of the electrospinning solutions prepared in this work.  
 
Sample 
 
Solution contents 
PNIPAAm to EL100-55 
ratio (w/w) 
KET  concentration 
(% w/v) 
S1 PNIPAAm/EL100-55 1:1 --- 
S2 PNIPAAm --- --- 
S3 EL100-55 --- --- 
S4 PNIPAAm/EL100-55 1:1 4.0 
S5 PNIPAAm --- 4.0 
S6 EL100-55 --- 4.0 
  
  
  
 
 
 
